Low dose dextromethorphan attenuates moderate experimental autoimmune encephalomyelitis by inhibiting NOX2 and reducing peripheral immune cells infiltration in the spinal cord
Dextromethorphan (DM) is a dextrorotary morphinan and a widely used component of cough medicine. Relatively high doses of DM in combination with quinidine are used for the treatment of mood disorders for patients with multiple sclerosis (MS). However, at lower doses, morphinans exert anti-inflammato...
Main Authors: | Olga V. Chechneva, Florian Mayrhofer, Daniel J. Daugherty, David E. Pleasure, Jau-Shyong Hong, Wenbin Deng |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2011-10-01
|
Series: | Neurobiology of Disease |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0969996111002026 |
Similar Items
-
Microglial Nox2 Plays a Key Role in the Pathogenesis of Experimental Autoimmune Encephalomyelitis
by: Chih-Fen Hu, et al.
Published: (2021-04-01) -
Anti-Axl antibody treatment reduces the severity of experimental autoimmune encephalomyelitis
by: Juwen C. DuBois, et al.
Published: (2020-10-01) -
NOX2 and NOX4 expression in monocytes and macrophages-extracellular vesicles in signalling and therapeutics
by: Deepak Rathi, et al.
Published: (2024-04-01) -
Nox2 activation in Covid-19
by: Francesco Violi, et al.
Published: (2020-09-01) -
Brain Renin-Angiotensin System and Microglial Polarization: Implications for Aging and Neurodegeneration
by: Jose L. Labandeira-Garcia, et al.
Published: (2017-05-01)